MENU
MCRB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Seres Therapeutics (MCRB) Earnings Date & Reports
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
MCRB is expected to report earnings to fall 448.94% to -163 cents per share on November 11
Q3'26
Est.
$-1.64
Q2'26
Beat
by $2.77
Q1'26
Missed
by $1.93
Q4'25
Missed
by $1.59
Q3'25
Beat
by $0.98
The last earnings report on August 05 showed earnings per share of 46 cents, beating the estimate of -229 cents. With 19.94K shares outstanding, the current market capitalization sits at 45.80M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of novel treatments for diseases related to the human microbiome
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
101 Cambridgepark Drive
Phone
+1 617 945-9626
Employees
66
Web
https://www.serestherapeutics.com